Eight Advisory supported SERB Pharmaceuticals in the entry of Aurlumyn ® in its emergency care portfolio in the United States
24 Oct 2024
Eight Advisory provided financial due diligence services to SERB Pharmaceuticals as part of its acquisition of the market authorization for Aurlumyn ®
Eight Advisory team members supporting on this transaction:
- Financial due diligence: Gennat Mouline (Partner), Arnaud Bensaid (Director)
Deals
Eight Advisory assisted Vantiva on the sale of its Supply Chain Solutions business unit to Variant Equity
30 Apr 2025
Read more
Deals
Eight Advisory advised Compagnie des Alpes on its investment in Terrésens
29 Apr 2025
Read more
Deals
Eight Advisory Avocats advised TagEnergy on the tax structuring of its investment together with Banque des Territoires (Caisse des Dépôts et Consignations) in Cernay Energy Storage
25 Apr 2025
Read more